Search

everythinglearnresearchcommunity

for

Search:↓

Meshushit ointment helps form thicker healing tissue and preserves hair follicles in burns.

Spironolactone effectively reduces unwanted hair growth in women with hirsutism.

The 7.1% withdrawal rate was in the oral finasteride group, not the topical one.

Many women with hair loss also have zinc deficiency, iron depletion, or thyroid issues.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Androgen receptor abnormalities may contribute to hair loss in androgenetic alopecia.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Warfarin is effective but risky, requiring careful monitoring to prevent bleeding.

Microspheres about 1.5 micrometers in size can best penetrate hair follicles, potentially reaching important stem cells.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Older adults diagnosed with lupus show less severe symptoms but have a lower survival rate, often due to age-related factors.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Male and female skin differ in many ways, which could lead to gender-specific skin treatments.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Androgen levels increase with puberty and are linked to sexual hair development.

Some treatments can help with a hair loss condition called alopecia areata, but none ensure lasting results; choices depend on the person, with JAK inhibitors showing promise for severe cases.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.